Preclinical studies partner

BIOEMTECH can offer full preclinical studies operating in a GLP environment. It covers a full chain of pre-clinical evaluation as follows: consulting and project management, cell testing (in vitro), animal model development, radiochemical protocol development for a wide range of isotopes and 'cold' chemistry tests, non-invasive molecular imaging studies in small laboratory animals (multi-modal in vivo imaging studies: optical, PET, SPECT, CT), advanced image processing, clinical chemistry tests, drug efficacy studies , GLP toxicology studies, ex vivo biodistributions as well as postmortem analyses. Also, the company develops molecular imaging systems, provides services in Nuclear Medicine technology and has additional expertise on software medical solutions using AI techniques and MC simulations.